Rishika Sadam on Muck Rack

Rishika Sadam

Verified
Hyderabad
As seen in: Reuters, MSN, MSN Ireland, MSN Singapore, Business Insider, Daily Mail, ET Healthworld, ETCFO, ETTelecom, HuffPost, MSN India and
Journalist @Reuters. Chai lover. Ex-ThePrint, CNNNews18, NewsX, Reuters. Personal views.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rishika

Contact Rishika, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

India limits cough syrup sales to pharmacies after contamination cases

|
By Rishika Sadam Verified
| Miami Herald Verified
FILE PHOTO: Saddam Mansuri shows a bottle of Coldrif cough syrup, which has been linked to the deaths of multiple children and which he had been giving to his one-year-old child, in Parasia, Madhya Pradesh, India, October 10, 2025. REUTERS/Priyanshu Singh/File Photo India has restricted cough syrup sales to licensed pharmacies especially in villages, preventing over-the-counter sales from retail outlets, as regulators step up scrutiny following contamination-linked child deaths last year.
Open in Who Shared View Duplicates (54) Issue with article?

India limits cough syrup sales to pharmacies after contamination cases

|
By Rishika Sadam Verified
| Salem Radio Network News Verified
India limits cough syrup sales to pharmacies after contamination cases By Rishika Sadam June 16 (Reuters) – India has restricted cough syrup sales to licensed pharmacies especially in villages, preventing over-the-counter sales from retail outlets, as regulators step up scrutiny following contamination-linked child deaths last year. Some cough syrups were previously on an exemption list under drug rules, allowing them to be sold over the counter as household remedies under relaxed regulations.
Open in Who Shared View Duplicates (2) Issue with article?

India raises price cap on cancer drugs to tackle shortage

|
By Rishika Sadam Verified
| Yahoo Verified
By Rishika Sadam June 12 (Reuters) - India's drug price regulator raised ceiling rates for two key platinum-based cancer drugs by 50% after a surge ‌in raw material costs triggered widespread shortages, according to a government notification ‌seen by Reuters. The National Pharmaceutical Pricing Authority invoked special provisions to raise rates for the drugs after ​receiving federal government approval citing public interest, according to the notification dated June 11.
Open in Who Shared View Duplicates (79) Issue with article?
See all 8,512 licensed articles (9,398 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified